Helius Medical Technologies, Inc. (HSDT)
USD 0.38
(-6.0%)
USD 0.38
(-6.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 61 Thousand USD | -131.17% |
| 2022 | 324 Thousand USD | 44.64% |
| 2021 | 224 Thousand USD | -17.95% |
| 2020 | 273 Thousand USD | -58.0% |
| 2019 | 650 Thousand USD | 35.98% |
| 2018 | 478 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 100.0% |
| 2015 | -171.78 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 5000.00 USD | -86.11% |
| 2024 Q2 | 64 Thousand USD | 1180.0% |
| 2023 Q2 | 72 Thousand USD | 754.55% |
| 2023 Q1 | -11 Thousand USD | -108.33% |
| 2023 Q4 | 36 Thousand USD | 181.82% |
| 2023 Q3 | -44 Thousand USD | -161.11% |
| 2023 FY | -101 Thousand USD | -131.17% |
| 2022 Q3 | 95 Thousand USD | 206.45% |
| 2022 Q1 | 66 Thousand USD | -48.84% |
| 2022 Q4 | 132 Thousand USD | 38.95% |
| 2022 FY | 324 Thousand USD | 44.64% |
| 2022 Q2 | 31 Thousand USD | -53.03% |
| 2021 Q3 | 23 Thousand USD | 475.0% |
| 2021 FY | 224 Thousand USD | -17.95% |
| 2021 Q1 | 69 Thousand USD | 790.0% |
| 2021 Q2 | 4000.00 USD | -94.2% |
| 2021 Q4 | 129 Thousand USD | 460.87% |
| 2020 Q4 | -10 Thousand USD | -109.17% |
| 2020 Q1 | 106 Thousand USD | 167.95% |
| 2020 Q2 | 69 Thousand USD | -34.91% |
| 2020 Q3 | 109 Thousand USD | 57.97% |
| 2020 FY | 273 Thousand USD | -58.0% |
| 2019 Q1 | 441 Thousand USD | -7.74% |
| 2019 FY | 650 Thousand USD | 35.98% |
| 2019 Q4 | -156 Thousand USD | -355.74% |
| 2019 Q3 | 61 Thousand USD | -80.07% |
| 2019 Q2 | 306 Thousand USD | -30.61% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | 478 Thousand USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 478 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 100.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | -171.78 Thousand USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 97.608% |
| BrainsWay Ltd. | 23.09 Million USD | 99.736% |
| Cerus Corporation | 86.4 Million USD | 99.929% |
| Envoy Medical, Inc. | -473 Thousand USD | 112.896% |
| electroCore, Inc. | 13.22 Million USD | 99.539% |
| IceCure Medical Ltd | 1.3 Million USD | 95.308% |
| Inogen, Inc. | 126.69 Million USD | 99.952% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.945% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 101.008% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 228.866% |
| MaxCyte, Inc. | 36.54 Million USD | 99.833% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 86.638% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 28.286% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.987% |
| PAVmed Inc | -3.96 Million USD | 101.537% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 101.112% |
| RxSight, Inc. | 53.76 Million USD | 99.887% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.912% |
| SI-BONE, Inc. | 109.42 Million USD | 99.944% |
| TELA Bio, Inc. | 40.11 Million USD | 99.848% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.96% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 99.262% |
| Acutus Medical, Inc. | -3.13 Million USD | 101.945% |
| Talis Biomedical Corporation | 371 Thousand USD | 83.558% |
| Spectral AI, Inc. | 7.88 Million USD | 99.226% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 100.925% |
| CVRx, Inc. | 33.03 Million USD | 99.815% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 91.751% |
| Bioventus Inc. | 328.19 Million USD | 99.981% |
| Venus Concept Inc. | 52.16 Million USD | 99.883% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 99.616% |
| LivaNova PLC | 771.25 Million USD | 99.992% |
| 908 Devices Inc. | 25.32 Million USD | 99.759% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.98% |
| Nemaura Medical Inc. | -1.47 Million USD | 104.132% |
| NeuroPace, Inc. | 48.12 Million USD | 99.873% |
| LENSAR, Inc. | 21.1 Million USD | 99.711% |
| Apyx Medical Corporation | 14.12 Million USD | 99.568% |
| Cutera, Inc. | 41.49 Million USD | 99.853% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 99.67% |
| BioSig Technologies, Inc. | 18 Thousand USD | -238.889% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.941% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 99.552% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.993% |
| Axonics, Inc. | 274.55 Million USD | 99.978% |
| Outset Medical, Inc. | 29 Million USD | 99.79% |
| IRIDEX Corporation | 21.8 Million USD | 99.72% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.914% |
| IRadimed Corporation | 50.15 Million USD | 99.878% |
| Tivic Health Systems, Inc. | 287 Thousand USD | 78.746% |
| INVO Bioscience, Inc. | 1.08 Million USD | 94.384% |
| Telesis Bio, Inc. | 16.95 Million USD | 99.64% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.946% |
| Varex Imaging Corporation | 256.9 Million USD | 99.976% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.963% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 115.025% |
| Pulmonx Corporation | 50.75 Million USD | 99.88% |
| Dynatronics Corporation | 7.63 Million USD | 99.201% |
| Modular Medical, Inc. | -768 Thousand USD | 107.943% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 98.901% |
| Semler Scientific, Inc. | 61.2 Million USD | 99.9% |
| InMode Ltd. | 411.34 Million USD | 99.985% |
| Bruker Corporation | 1.51 Billion USD | 99.996% |
| Cytosorbents Corporation | 22.39 Million USD | 99.728% |
| DexCom, Inc. | 2.28 Billion USD | 99.997% |
| Align Technology, Inc. | 2.71 Billion USD | 99.998% |
| Viveve Medical, Inc. | 620 Thousand USD | 90.161% |
| ZimVie Inc. | 290.38 Million USD | 99.979% |
| Movano Inc. | -158 Thousand USD | 138.608% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.944% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 28.286% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.983% |
| Profound Medical Corp. | 4.51 Million USD | 98.649% |
| Insulet Corporation | 1.15 Billion USD | 99.995% |
| enVVeno Medical Corporation | -546 Thousand USD | 111.172% |
| Surmodics, Inc. | 93.05 Million USD | 99.934% |
| iCAD, Inc. | 14.53 Million USD | 99.58% |
| Nuwellis, Inc. | 4.98 Million USD | 98.776% |
| Biotricity, Inc. | 8.35 Million USD | 99.27% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.982% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 116.989% |
| InspireMD, Inc. | 1.8 Million USD | 96.624% |
| PAVmed Inc. | -3.96 Million USD | 101.537% |
| BIOLASE, Inc. | 16.72 Million USD | 99.635% |
| Beyond Air, Inc. | -1.3 Million USD | 104.667% |
| FONAR Corporation | 45.14 Million USD | 99.865% |
| AxoGen, Inc. | 127.87 Million USD | 99.952% |
| Vivani Medical, Inc. | -357 Thousand USD | 117.087% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.969% |
| Inari Medical, Inc. | 434.56 Million USD | 99.986% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.946% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -387.259% |
| Tenon Medical, Inc. | 1.24 Million USD | 95.085% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 175.309% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 97.678% |
| AdaptHealth Corp. | 479.56 Million USD | 99.987% |
| Sintx Technologies, Inc. | 1.84 Million USD | 96.69% |
| NanoVibronix, Inc. | 1.53 Million USD | 96.031% |
| Quanterix Corporation | 70.64 Million USD | 99.914% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 115.025% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 99.566% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 99.884% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.96% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 98.63% |
| NeuroMetrix, Inc. | 3.94 Million USD | 98.455% |
| Hyperfine, Inc. | 4.75 Million USD | 98.718% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.943% |
| Biomerica, Inc. | 611 Thousand USD | 90.016% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 99.854% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 107.811% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.952% |